Antibiotic Management of Acute Submandibular Sialadenitis

Empiric Oral Therapy

Amoxicillin‑clavulanate 875 mg/125 mg twice daily is the preferred first‑line oral agent for acute submandibular sialadenitis because it covers Staphylococcus aureus and streptococci and attains high salivary concentrations. 1
Cephalexin 500 mg four times daily is an acceptable alternative for patients with non‑immediate‑type penicillin allergy. 2
Clindamycin 300–450 mg three times daily provides reliable coverage of staphylococci, streptococci, and anaerobes, but carries a higher risk of Clostridioides difficile infection. 3

Nafcillin or oxacillin 1–2 g every 4 hours IV is recommended for methicillin‑susceptible S. aureus (MSSA) infections. [2][4]
Cefazolin 1 g every 8 hours IV is suitable for patients with penicillin allergy who do not have an immediate hypersensitivity reaction. [2][4]
Vancomycin 15–20 mg/kg dose every 8–12 hours IV should be used when MRSA is suspected or confirmed. [4][3]

For patients with non‑Type I hypersensitivity (e.g., rash), cephalosporins remain appropriate. 5
For patients with true Type I (immediate) hypersensitivity, clindamycin or a fluoroquinolone should be selected. [2][4]

When recent hospitalization, healthcare exposure, or known colonization raises concern for MRSA, initiate vancomycin 15–20 mg/kg every 8–12 hours IV or linezolid 600 mg twice daily. [4][3]

Add gram‑negative coverage by incorporating ciprofloxacin 400 mg IV every 12 hours or ceftriaxone 1 g daily to the regimen. [6][7]

Persistent fever or worsening swelling despite appropriate antibiotics warrants evaluation for abscess formation and possible surgical drainage. 3